Evidence map›Paper›PMID 32854778›Full record

ArticleStem cell research & therapy2020

Extracellular vesicles derived from mesenchymal stromal cells mitigate intestinal toxicity in a mouse model of acute radiation syndrome.

Alison Accarie, Bruno l'Homme, Mohamed Amine Benadjaoud, Sai Kiang Lim, Chandan Guha, Marc Benderitter, Radia Tamarat, Alexandra Sémont

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Radiomitigators: Breakthroughs in Post-Radiation Recovery.Antioxidants (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Alison AccarieLaboratory of Medical Radiobiology, Fontenay-aux-Roses, France.
Bruno l'HommeDepartment of Research in Radiobiology and Regenerative Medicine, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-Roses, France.
Mohamed Amine BenadjaoudLaboratory of Accidental Radiobiology, Department of Research in Radiobiology and Regenerative Medicine, Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.
Sai Kiang LimInstitute of Molecular and Cellular Biology, Agency for Science, Technology and Research, Singapore, Singapore.
Chandan GuhaDepartment of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA.
Marc BenderitterLaboratory of Accidental Radiobiology, Department of Research in Radiobiology and Regenerative Medicine, Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.
Radia TamaratLaboratory of Accidental Radiobiology, Department of Research in Radiobiology and Regenerative Medicine, Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.
Alexandra SémontLaboratory of Medical Radiobiology, Fontenay-aux-Roses, France. alexandra.semont@irsn.fr.ORCID 0000-0003-3444-5895
CEA Paris-Saclay - Etablissement de Fontenay-aux-roses · FRAgency for Science, Technology and Research · SGAlbert Einstein College of Medicine · USInstitut de Radioprotection et de Sûreté Nucléaire · FR

Funding

Stem Cell-Based Therapies for Radiation-Induced Gastrointestinal Sydrome (RIGS)U19AI091175 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI FLEMING, WILLIAM H · 2010 to 2014
$13.1M
Intestinal Stem Cell Consortium Coordinating CenterU01DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2009 to 2018
$6.5M
Understanding stem cell heterogeneity and niche function in intestinal regeneration after irradiationU01DK103155 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GUHA, CHANDAN, WANG, TIMOTHY CRAGIN · 2014 to 2023
$4.4M
Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating CenterU24DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2019 to 2023
$2.3M
NIAID NIH HHS U19 AI091175NIDDK NIH HHS U01 DK085532NIDDK NIH HHS U01 DK103155NIDDK NIH HHS U24 DK085532
6 · The paper itself

Abstract

backgroundHuman exposure to high doses of radiation resulting in acute radiation syndrome and death can rapidly escalate to a mass casualty catastrophe in the event of nuclear accidents or terrorism. The primary reason is that there is presently no effective treatment option, especially for radiation-induced gastrointestinal syndrome. This syndrome results from disruption of mucosal barrier integrity leading to severe dehydration, blood loss, and sepsis. In this study, we tested whether extracellular vesicles derived from mesenchymal stromal cells (MSC) could reduce radiation-related mucosal barrier damage and reduce radiation-induced animal mortality.

methodsHuman MSC-derived extracellular vesicles were intravenously administered to NUDE mice, 3, 24, and 48 h after lethal whole-body irradiation (10 Gy). Integrity of the small intestine epithelial barrier was assessed by morphologic analysis, immunostaining for tight junction protein (claudin-3), and in vivo permeability to 4 kDa FITC-labeled dextran. Renewal of the small intestinal epithelium was determined by quantifying epithelial cell apoptosis (TUNEL staining) and proliferation (Ki67 immunostaining). Statistical analyses were performed using one-way ANOVA followed by a Tukey test. Statistical analyses of mouse survival were performed using Kaplan-Meier and Cox methods.

resultsWe demonstrated that MSC-derived extracellular vesicle treatment reduced by 85% the instantaneous mortality risk in mice subjected to 10 Gy whole-body irradiation and so increased their survival time. This effect could be attributed to the efficacy of MSC-derived extracellular vesicles in reducing mucosal barrier disruption. We showed that the MSC-derived extracellular vesicles improved the renewal of the small intestinal epithelium by stimulating proliferation and inhibiting apoptosis of the epithelial crypt cells. The MSC-derived extracellular vesicles also reduced radiation-induced mucosal permeability as evidenced by the preservation of claudin-3 immunostaining at the tight junctions of the epithelium.

conclusionsMSC-derived extracellular vesicles promote epithelial repair and regeneration and preserve structural integrity of the intestinal epithelium in mice exposed to radiation-induced gastrointestinal toxicity. Our results suggest that the administration of MSC-derived extracellular vesicles could be an effective therapy for limiting acute radiation syndrome.

Indexed as

Acute Radiation SyndromeExtracellular VesiclesMesenchymal Stem CellsAnimalsIntestinal MucosaIntestinesMiceMice, NudeAcute radiation syndromeGastrointestinal syndromeIntestinal epithelial barrierMedical countermeasuresMesenchymal stromal cell-derived extracellular vesicles

Identifiers

PMID32854778
PMCPMC7457304
OpenAlexW3082047193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.